The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
May. 18, 2021
Filed:
Dec. 16, 2019
Applicant:
Taris Biomedical Llc, Lexington, MA (US);
Inventor:
Dennis Giesing, Lee's Summit, MO (US);
Assignee:
TARIS Biomedical LLC, Lexington, MA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61M 31/00 (2006.01); A61K 9/00 (2006.01); A61P 35/00 (2006.01); A61K 31/555 (2006.01); A61K 31/282 (2006.01); A61K 45/06 (2006.01); A61K 31/7048 (2006.01);
U.S. Cl.
CPC ...
A61M 31/002 (2013.01); A61K 9/0034 (2013.01); A61K 31/282 (2013.01); A61K 31/555 (2013.01); A61K 31/7048 (2013.01); A61K 45/06 (2013.01); A61P 35/00 (2018.01); A61M 2205/04 (2013.01); A61M 2210/1085 (2013.01); A61M 2210/1096 (2013.01); A61M 2210/166 (2013.01);
Abstract
Devices and methods are provided for use in the treatment of bladder cancer by locally administering oxaliplatin into the bladder of a patient to achieve a sustained concentration of oxaliplatin in urine in the bladder sufficient to produce a therapeutic concentration of oxaliplatin in bladder tissue. The oxaliplatin may be delivered into the bladder from an intravesical drug delivery device inserted into the bladder, wherein the device continuously releases the oxaliplatin into the urine in the bladder over an extended period of hours or days.